On April 29th Anthony Fauci announced the National Institute of Allergy and Infectious Diseases, an institute he runs, had completed a study of the antiviral remdesivir for COVID-19. The drug reduced time to recovery from 15 to 11 days, he said, a breakthrough proving "a drug can block this virus." Now people are clamoring for $1,000-a-pill remdesivir. While the results were preliminary, unpublished, and unconfirmed by ...

Read more...

In January, we learned of an emerging threat in China, a variant of the frightening SARS virus, but worse—more infectious. Since then, we learned China, the first to both see and successfully manage its outbreak, seriously under-detected the disease. According to a widely circulated computer model study, true cases were probably around seven times greater than the official count. Calculations published a ...

Read more...

1 Pages

Most Popular

✓ Join 150,000+ subscribers
✓ Get KevinMD's most popular stories